Rapidly growing pan-Latin American specialty pharmaceutical company, focused on oncology and critical care drugs

Rapidly growing pan-Latin American specialty pharmaceutical company

Biotoscana is a rapidly growing pan-Latin American specialty pharmaceutical company, headquartered in Bogotá, with operations across the region and a broad portfolio of high-value specialty pharmaceutical products as well as generics. Biotoscana was founded as a family owned business in 1994 and has expanded rapidly across the region. Today, Biotoscana has operations in Colombia, Brazil, Argentina, Chile, Ecuador and Peru. Biotoscana expanded into Brazil in 2014 when it agreed to acquire United Medical, a leading specialty pharma company focused on therapies to serve significant unmet needs. The company sells a mixture of specialty pharmaceuticals and branded generics and in recent years has increasingly focused on growing the specialty pharmaceutical business with novel, high-value products in-licensed from global pharmaceutical companies.

Essex Woodlands, together with Advent International, a leading Latin American private equity company, acquired a controlling stake in Biotoscana at the end of 2011. This is the first investment for Essex Woodlands in Latin America, a region in which economic growth, rising prosperity and government efforts are enabling an increasing number of people to gain access to healthcare.

Related News

“Essex’s deep healthcare expertise, industry relationships and strategic insights are helping Biotoscana achieve its mission of being the high growth specialty pharma company in Latin America.”

Mariano Garcia-Valino

CEO, Biotoscana